Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: Nature. 2018 Jul 9;559(7714):400–404. doi: 10.1038/s41586-018-0317-6

Extended Data Figure 1. Prevalence of ARCH-PD mutations with VAF ≥ 10% according to age.

Extended Data Figure 1

Red and blue lines represent the proportion of pre-AMLs and controls, respectively, harbouring ARCH-PD mutations with VAF ≥10%.